Valuation: Diaceutics PLC

Market Cap 17Cr 23Cr 20Cr 19Cr 32Cr 2.16TCr 33Cr 226.62Cr 89Cr 1.14TCr 86Cr 84Cr 3.62TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 16Cr 22Cr 19Cr 18Cr 31Cr 2.06TCr 31Cr 216.37Cr 85Cr 1.09TCr 82Cr 80Cr 3.46TCr EV / Sales 2026 *
3.5x
EV / Sales 2027 * 2.85x
Free-Float
72%
Yield 2026 *
-
Yield 2027 * -
1 day-0.25%
1 week-0.74%
Current month+4.96%
1 month+8.06%
3 months+52.27%
6 months+15.52%
Current year+57.03%
1 week 200
Extreme 200
210
1 month 185
Extreme 185
210
Current year 125
Extreme 125
210
1 year 125
Extreme 125
210
3 years 82
Extreme 82
210
5 years 74
Extreme 74
210
10 years 74
Extreme 74
210
Manager TitleAgeSince
Chief Executive Officer 42 01/01/2024
Director of Finance/CFO - 18/03/2022
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 01/10/2024
Director/Board Member 42 -
Director/Board Member 42 01/10/2024
Date Insider Type Main position Quantity % Market Cap. Importance
05/05/26 Buy

Chief Financial Officer

90 0.0001%
05/05/26 Free

Chief Financial Officer

90 0.0001%
05/05/26 Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.25%-0.74%+25.23%+129.71% 23Cr
+0.31%+4.19%+17.46%+74.76% 75TCr
+1.44%+5.52%+12.04%+76.76% 8.74TCr
+2.41%+3.30%+6.65%+163.04% 6.65TCr
+0.11%+1.96%-18.34%+7.14% 4.89TCr
+0.14%+3.11%+0.62%+77.83% 4.73TCr
+0.07%-7.76%+64.53%+805.86% 4.7TCr
+1.95%+3.82%+8.52%+36.66% 3.22TCr
-0.20%+3.70%+41.79%+70.53% 2.68TCr
-0.08%+4.65%-61.76%-56.37% 2.56TCr
Average +0.09%+2.20%+9.67%+138.59% 11.31TCr
Weighted average by Cap. +0.02%+3.59%+14.64%+103.57%

Financials

2026 *2027 *
Net sales 4.67Cr 6.26Cr 5.58Cr 5.16Cr 8.8Cr 590.49Cr 8.91Cr 62Cr 24Cr 310.39Cr 23Cr 23Cr 989.06Cr 5.63Cr 7.55Cr 6.72Cr 6.23Cr 11Cr 712.13Cr 11Cr 75Cr 29Cr 374.32Cr 28Cr 28Cr 1.19TCr
Net income -11L -14.73L -13.13L -12.16L -20.72L -14Cr -20.97L -1.46Cr -57.18L -7.31Cr -55.27L -54.12L -23Cr 28.5L 38.17L 34.02L 31.49L 53.69L 36Cr 54.33L 3.78Cr 1.48Cr 19Cr 1.43Cr 1.4Cr 60Cr
Net Debt -77.29L -1.04Cr -92.25L -85.41L -1.46Cr -98Cr -1.47Cr -10Cr -4.02Cr -51Cr -3.88Cr -3.8Cr -163.63Cr -1.04Cr -1.39Cr -1.24Cr -1.15Cr -1.96Cr -131.39Cr -1.98Cr -14Cr -5.4Cr -69Cr -5.22Cr -5.11Cr -220.08Cr
Projected Income Statement - Annual - Diaceutics PLC
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
22/26/22 GBX 201.00 -0.25% 1,58,411
21/26/21 GBX 201.50 -1.47% 3,05,114
20/26/20 GBX 204.50 0.00% 49,913
19/26/19 GBX 204.50 +0.49% 1,67,477
16/26/16 GBX 203.50 +0.49% 5,75,986
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Diaceutics PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
2.015GBP
Average target price
2.130GBP
Spread / Average Target
+5.71%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Diaceutics PLC
  1. Stock Market
  2. Stocks
  3. DXRX Stock